China NMPA Product Recall - Metal intramedullary nail system

The National Medical Products Administration (NMPA) issued a notice on February 21, 2023, concerning a voluntary Class III recall of the Synthes G Intramedullary Nail System. The recall was initiated by the manufacturer, Synthes GmbH, and reported by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. The primary issue identified is a significant discrepancy between the product's labeled length and its actual physical length for a specific model and batch. This classification indicates that the use of or exposure to the affected product is not likely to cause adverse health consequences. The NMPA, as the regulatory authority, published this information to ensure transparency regarding medical device safety. As a required action, Synthes GmbH is voluntarily withdrawing the affected products from the market to correct the labeling inaccuracy. Comprehensive details regarding the specific models, specifications, and batch numbers involved are provided in an attached "Medical Device Recall Event Report Form," which affected parties should consult for further guidance. This recall highlights the critical importance of accurate product information for medical devices to ensure appropriate use and patient safety.